Skip to main content

Header

For Healthcare Professionals

Global Website Opens in new tab

Contact us Opens in new tab

Boehringer Ingelheim

CRM
Therapeutic Areas
Therapeutic Areas

We combat interconnected cardio-renal-metabolic issues that cause 20 million deaths annually as part of our efforts to address global health threats. Innovative, comprehensive treatments are given priority in our R&D.
Read more

Therapeutic Areas

Pustular Psoriasis

Heart Failure

Type 2 Diabetes Mellitus
Product
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products

Product

Glyxambi Opens in new tab

Jardiance

Jardiance Met

Spevigo

Trajenta® Opens in new tab

Trajenta Duo® Opens in new tab
Patient support
Patient support

Innovation at Boehringer Ingelheim is driven by patients. Our commitment lies in investigating unaddressed needs and providing revolutionary treatments for upcoming generations.
Read more Opens in new tab

Patient support

Ashwasan

Empower clinic

HF Risk score

Patient education leaflet

Fact Clinic Opens in new tab
Global Website Opens in new tab
Contact us Opens in new tab

Boehringer Ingelheim

Heart Failure - Treatment Guidelines

Heart Failure

Disease classification
Treatment guidelines
Clinical Trials
Resources
Patient Tools

Home
Heart Failure - Treatment Guidelines

Glyxambi

Privacy notice Opens in new tab
Terms of use Opens in new tab
Sitemap Opens in new tab
Contact us Opens in new tab

This information is for India residents only. Products discussed herein may have different labelling in different countries.
Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.